mibefradil has been researched along with Allodynia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, HJ; Lee, YS; Pae, AN; Roh, EJ; Seo, SH; Shin, KJ; Song, CM; Woo, HM | 1 |
| Abbasloo, E; Abdollahi, F; Akhlaghinasab, F; Esmaeili-Mahani, S; Kaeidi, A; Kobeissy, FH; Oryan, S; Saberi, A; Sheibani, V; Thomas, TC | 1 |
| Hong, SJ; Hwang, SM; Jevtovic-Todorovic, V; Obradovic, ALj; Scarpa, J; Todorovic, SM | 1 |
| Wang, J; Wang, XW; Yin, CP; Yue, SW; Zhang, Y | 1 |
| Kumamoto, N; Shibata, Y; Shimada, S; Ueda, T; Ugawa, S; Watanabe, M | 1 |
| Aoki, Y; Kawabata, A; Maeda, Y; Matsunami, M; Nishikawa, H; Sekiguchi, F; Takahashi, T | 1 |
| Fukushima, O; Ishikura, H; Kamanaka, Y; Kawabata, A; Matsunami, M; Naruse, M; Nishimura, S; Sekiguchi, F; Takahashi, T; Tsujiuchi, T | 1 |
| Chen, ZX; Li, H; Liang, H; Wen, XJ; Xu, SY; Yang, CX | 1 |
| Aoki, Y; Kawabata, A; Maeda, Y; Mitani, K; Nishikawa, H; Okubo, K; Sekiguchi, F; Takahashi, T | 1 |
| Barton, ME; Eberle, EL; Shannon, HE | 1 |
10 other study(ies) available for mibefradil and Allodynia
| Article | Year |
|---|---|
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Hyperalgesia; Inhibitory Concentration 50; Ligands; Mibefradil; Molecular Structure; Molecular Targeted Therapy; Neuralgia; Patch-Clamp Techniques; Piperidines; Quantitative Structure-Activity Relationship; Rats; Spinal Nerves; Structure-Activity Relationship | 2011 |
Involvement of T-type calcium channels in the mechanism of low dose morphine-induced hyperalgesia in adult male rats.
Topics: Amiloride; Analgesics, Opioid; Animals; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Intraperitoneal; Male; Mibefradil; Morphine; Pain Measurement; Pain Threshold; Posterior Horn Cells; Rats; Rats, Wistar; Receptors, Opioid, mu | 2021 |
CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Hyperalgesia; Mibefradil; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Streptozocin | 2014 |
Ca(2+) influx mediates the TRPV4-NO pathway in neuropathic hyperalgesia following chronic compression of the dorsal root ganglion.
Topics: Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Ganglia, Spinal; Hyperalgesia; Male; Mibefradil; Nerve Compression Syndromes; Neuralgia; NF-kappa B; Nitric Oxide; Phorbols; Rats, Wistar; RNA, Small Interfering; Signal Transduction; TRPV Cation Channels | 2015 |
Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
Topics: Analgesics; Animals; Benzimidazoles; Calcium Channels, T-Type; Cyclopropanes; Ganglia, Spinal; Hyperalgesia; Inflammation; Mibefradil; Mice; Naphthalenes; Neuralgia; Neurons | 2015 |
Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Topics: Analysis of Variance; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Cerebellum; Disease Models, Animal; Ganglia, Spinal; Hydrogen Sulfide; Hyperalgesia; Male; Mibefradil; Oligodeoxyribonucleotides, Antisense; Pain Threshold; Rats; Rats, Wistar; Spinal Cord | 2009 |
Hydrogen sulfide as a novel mediator for pancreatic pain in rodents.
Topics: Alkynes; Animals; Blotting, Western; Calcium Channel Blockers; Calcium Channels, T-Type; Capsaicin; Ceruletide; Cystathionine gamma-Lyase; Ganglia, Spinal; Glycine; Hydrogen Sulfide; Hyperalgesia; Immunohistochemistry; Male; Mibefradil; Mice; Nociceptors; Oncogene Proteins v-fos; Pancreas; Pancreatitis, Acute Necrotizing; Rats; Rats, Wistar; Sulfides | 2009 |
The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Topics: Animals; Behavior, Animal; Calcium Channel Blockers; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression Regulation; Hot Temperature; Hyperalgesia; Lumbar Vertebrae; Male; Mibefradil; Nerve Compression Syndromes; Neuralgia; Protein Isoforms; Random Allocation; Rats; Rats, Sprague-Dawley; Reaction Time; RNA, Messenger; Time Factors; Touch | 2010 |
Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
Topics: Animals; Blotting, Western; Calcium Channel Blockers; Calcium Channels, T-Type; Hydrogen Sulfide; Hyperalgesia; Immunohistochemistry; Male; Mibefradil; Neuralgia; Neurons, Afferent; Pain Threshold; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Spinal Nerves; Up-Regulation | 2010 |
The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil.
Topics: Animals; Anticonvulsants; Behavior, Animal; Calcium Channel Blockers; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Ethosuximide; Hyperalgesia; Male; Mibefradil; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Time Factors; Trimethadione | 2005 |